Prolonged neurological sequelae after combination treatment with lithium and antipsychotic drugs

Mani, J; Tandel, S V; Shah, P U; Karnad, D R
March 1996
Journal of Neurology, Neurosurgery & Psychiatry;Mar1996, Vol. 60 Issue 3, p350
Academic Journal
case study
No abstract available.


Related Articles

  • Lithium/antidepressants/antiepileptic drugs/antipsychotics.  // Reactions Weekly;10/19/2013, Issue 1474, p28 

    The article presents case studies of four women, aged 39-78 years, who developed lithium toxicity that led to neurological sequelae while treating with lithium, antidepressants, antiepileptic drugs and antipsychotics.

  • QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Sala, Michela; Vicentini, Alessandro; Brambilla, Paolo; Montomoli, Cristina; Jogia, Jigar R. S.; Caverzasi, Eduardo; Bonzano, Alberto; Piccinelli, Marco; Barale, Francesco; De Ferrari, Gaetano M. // Annals of General Psychiatry;2005, Vol. 4, p1 

    Background: Several antipsychotic agents are known to prolong the QT interval in a dose dependent manner. Corrected QT interval (QTc) exceeding a threshold value of 450 ms may be associated with an increased risk of life threatening arrhythmias. Antipsychotic agents are often given in...

  • What is the best way to treat bipolar depression? Silverstone, Peter // Journal of Psychiatry & Neuroscience;Sep2005, Vol. 30 Issue 5, p384 

    Provides a suggested approach for the treatment of bipolar depression. Prescription of antidepressants to patients suffering from the disease including lithium or lamotrigine; Efficacy of drug combination with other antidepressants; Role of antipsychotics in bipolar depression in the treatment...

  • Neurotoxicity and nephrotoxicity caused by combined use of lithium and risperidone: a case report and literature review. Chih-Wei Hsu; Yu Lee; Chun-Yi Lee; Pao-Yen Lin // BMC Pharmacology & Toxicology;12/14/2016, Vol. 17, p1 

    Background: Combination lithium, a mood stabilizer, and risperidone, an atypical antipsychotic drug, is widely used for treatment of psychotic disorders. Rare reports concern severe adverse drug reaction in multiple organic systems with their combined use. We report two episodes of neurotoxicity...

  • Total collected dialysate lithium concentration after successful dialysis treatment in case of intoxication. Schmidt, Julius J.; Lorenzen, Johan; Chatzikyrkou, Christos; Lichtinghagen, Ralf; Kielstein, Jan T. // BMC Pharmacology & Toxicology;2014, Vol. 15 Issue 1, p49 

    Background: Lithium intoxication has potentially fatal neurologic and cardiac side effects. Extracorporeal removal can therefore be lifesaving. The dialysance of lithium is high as it is a small molecule. Comparable to its neighbor in the periodic table, sodium, its intracellular accumulation...

  • Lityumun Kırk Yıldır Sorunsuz Kullanımı: Olgu Sunumu. Ünal, Ahmet; Sertan Çöpoğlu, Ümit; Bülbül, Feridun; Vırıt, Osman; Asuman Savaş, Haluk // Journal of Mood Disorders;2013, Vol. 3 Issue 2, p70 

    Lithium's first rise in psychiatry was in 1949 when John Cade tried lithium in manic patients successfully. Clinical research which conducted later on, showed the lithium's effectivity in maintenance treatment of bipolar disorder (BD) and mania. On the other hand, U.S. Food and Drug...

  • Drug Interactions with Lithium: A Guide for Clinicians. Müller-Oerlinghausen, B. // CNS Drugs;1999, Vol. 11 Issue 1, p41 

    Long term lithium treatment will often be combined with other pharmacological treatments, due to the need to treat insomnia or anxiety, breakthrough episodes, co-existing psychiatric (schizoaffective psychoses) or non-psychiatric (particularly in elderly patients) disorders, or self-medication...

  • Diuretics are dangerous with lithium. Kerry, R.J.; Ludlow, J.M.; Owen, G. // British Medical Journal;8/2/1980, Vol. 281 Issue 6236, p371 

    Investigates the dangers of uncontrolled prescription of diuretics to patients receiving lithium. Treatment of a manic-depressive patient; Estimation of serum lithium concentration on daily basis; Relapse of mania after prolonged intake of lithium.

  • Addition of Lithium Therapy in a Patient with Persistent Neutropenia Triggered with Antipsychotics. Yilmaz, Gorkem; Erten, Evrim; Fistikci, Nurhan; Erek, Sakire; Saatcioglu, Omer // Dusunen Adam: Journal of Psychiatry & Neurological Sciences;Mar2014, Vol. 27 Issue 1, p78 

    Addition of lithium therapy in a patient with persistent neutropenia triggered with antipsychotics Decrease in leukocyte count might be seen during the use of antipsychotic medications. In such cases, treatment can be stopped or changed and blood count values must be closely monitored. As in...

  • Cardiac risk and schizophrenia. Jindal, Ripu; MacKenzie, Erin M.; Baker, Glen B.; Yeragani, Vikram K. // Journal of Psychiatry & Neuroscience;Nov2005, Vol. 30 Issue 6, p393 

    Reports on the public health risk posed by sudden cardiac death after symptoms initially appear often without warning. Indication that patients with schizophrenia have been reported to be three times as likely to experience sudden unexpected death that individuals from the general population;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics